Trials / Completed
CompletedNCT02530827
Energy Expenditure of People Living With HIV/AIDS
Influence of Lipid-lowering Drugs in Patients Seropositive for HIV With Lipodystrophy in Resting Energy Expenditure and Total Energy Expenditure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- University of Sao Paulo General Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Background: Several studies have reported increased resting energy expenditure (REE) in people living with HIV/AIDS possibly due to changes in body composition that occurs in HIV lipodystrophy syndrome. The aim of this study was to evaluate the influence of the use of lipid-lowering drugs in resting energy expenditure (REE) and total energy expenditure (TEE) in patients seropositive for HIV in treatment of lipodystrophy.
Detailed description
REE was measured by indirect calorimetry. TEE was measured by doubly labeled water (DLW) technique and an activity monitor based on accelerometry (AM).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | use of lipid-lowering drugs. | The patients shoud be in use of a lipid-lowering drugs previouly, at least one month before of the begining of the study. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-11-01
- First posted
- 2015-08-21
- Last updated
- 2015-08-21
Source: ClinicalTrials.gov record NCT02530827. Inclusion in this directory is not an endorsement.